CurePSP Center of Care

The Neurological Institute at Columbia University Irving Medical Center has been designated a Center of Care by CurePSP. This award acknowledges our excellence and leadership in research, comprehensive care, professional education, and patient outreach related to atypical parkinsonian syndromes (i.e. progressive supranuclear palsy-PSP, multiple system atrophy-MSA, and cortical basal degeneration-CBD).

The CurePSP Center of Care is co-directed by Dr. Serge Przedborski and Dr. Lawrence Honig. Dr. Przedborski is currently the chief of the Division of Movements Disorders. He is a movement disorders specialist with academic interests that focus on the molecular and cellular biology of neurodegenerative disorders such as Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS). Dr. Lawrence Honig directs the New York State Center of Excellence for Alzheimer’s Disease, and he is a principal investigator for both observational research and clinical drug trials for neurodegenerative conditions including Alzheimer Disease, Frontotemporal Degeneration, Lewy Body Disease, and Progressive Supranuclear Palsy.

Our patient advocacy partner, CurePSP, also provides our center with a wide array of educational materials for distribution to our patients and can also be found electronically on the CurePSP website

Interdisciplinary Team of Experts

The CurePSP Center of Care at CUIMC offers patients and their families comprehensive, specialized care for atypical parkinsonian syndromes. Our interdisciplinary team of experts is trained to address the physical, cognitive, and emotional needs of those coming to our clinic. We actively work with patients and their families to develop individualized treatment plans and recommendations.

Our team includes specialists from the following areas:

Neurology/Movement Disorders/Aging and Dementia

  • Neurosurgery
  • Physical Therapy
  • Occupational Therapy
  • Speech and Language Pathology
  • Neuropsychology
  • Social Work


The CurePSP Center of Care at CUIMC is also actively engaged in outstanding clinical and basic science research in atypical parkinsonian syndromes. Dr. Honig has acted as principal investigator for clinical trials and observational research. In addition to PSP, our center is expanding its research efforts to also include MSA and CBD. 

Please follow this link to learn more about our current clinical trials.